1860-P: Impact of Physical Activity on the Night Outcomes with the DBLG1 System
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-1860-p ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ALICE ADENIS und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Physical activity (PA) increases insulin sensitivity in people with T1D, elevating nocturnal hypoglycemia risk. We evaluated the safety and efficacy of the DBLG1 System during the night following declared PA compared to nights following days without PA.
Methods
We analyzed real-world data from 2,322 adults (61% female, median age 42 years, median HbA1c 7.4%). We compared 17,666 nights (12:00 PM-6:00 AM) following a PA session to matched control nights from non-PA periods (shifted 24/48 hours prior). Dependent variables included Time Below Range (TBR <70 mg/dL), Time in Range (TIR 70-180 mg/dL), total insulin delivery and rescue carbohydrate intake (RC). Differences were assessed using paired t-tests and Cohen’s d for effect size.
Results
Nocturnal safety was equivalent between groups (Table 1): TBR remained identical at 1.07% (p=0.937). This stability was achieved through automated insulin reduction (-0.2 IU; p<0.001) rather than increased carbohydrate intake, as RC remained stable (2.5g vs 2.6g; p=0.47). TIR was maintained at a high level (81.3% vs 81.8%), with a negligible effect size (Cohen’s d = -0.019).
Conclusion
The DBLG1 System effectively manages post-exercise nocturnal hypoglycemia risk. The algorithm successfully adapts to increased insulin sensitivity by modulating delivery rather than relying on additional rescue carbohydrates, ensuring that nights following activity are as safe as nights following sedentary periods. Disclosure A. Adenis: Employee; Current; Diabeloop SA. S. Lachal: Employee; Current; Diabeloop SA. P. Gauthier: Employee; Current; Diabeloop SA. P. Gimenez: Employee; Current; Diabeloop SA. C. Desir: Employee; Current; Diabeloop SA. T. Le Roux-Mallouf: None. E. Huneker: Employee; Current; Diabeloop SA. P.Y. Benhamou: Employee; Current; Diabeloop SA. Advisory Panel; Ended; Eli Lilly and Company, Novo Nordisk.
Zitieren
APA
ADENIS, A., LACHAL, S., GAUTHIER, P., GIMENEZ, P., DESIR, C., ROUX-MALLOUF, T. L., HUNEKER, E., & BENHAMOU, P. Y. (2026). 1860-P: Impact of Physical Activity on the Night Outcomes with the DBLG1 System. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1860-p
Vancouver
ADENIS A, LACHAL S, GAUTHIER P, GIMENEZ P, DESIR C, ROUX-MALLOUF TL, et al. 1860-P: Impact of Physical Activity on the Night Outcomes with the DBLG1 System. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1860-p
BibTeX
@article{ADENIS2026,
author = {ADENIS, ALICE and LACHAL, SYLVAIN and GAUTHIER, PIERRE and GIMENEZ, PAUL and DESIR, CHESNER and ROUX-MALLOUF, THIBAULT LE and HUNEKER, ERIK and BENHAMOU, PIERRE Y.},
title = {1860-P: Impact of Physical Activity on the Night Outcomes with the DBLG1 System},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-1860-p}
}
EUVIMED